Last synced on 2 May 2025 at 11:05 pm

Mycophenolic Acid Test System

Page Type
Product Code
Definition
An in vitro diagnostic reagent system intended for use in the quantitative determination of total mycophenolic acid in human serum or plasma as an aid in the management of mycophenolic acid therapy in renal and cardiac transplant patients.
Physical State
Liquid
Technical Method
Enzyme-mimicking assay with MPA concentration inversely proportional to the formation of NADH.
Target Area
Renal and Cardiac Transplant Patients
Regulation Medical Specialty
Toxicology
Review Panel
Toxicology
Submission Type
510(K)
Device Classification
Class 2
Regulation Number
862.3840
GMP Exempt?
No
Summary Malfunction Reporting
Eligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Third Party Eligible

CFR § 862.3840 Sirolimus test system

§ 862.3840 Sirolimus test system.

(a) Identification. A sirolimus test system is a device intended to quantitatively determine sirolimus concentrations in whole blood. Measurements are used as an aid in management of transplant patients receiving therapy with sirolimus.

(b) Classification. Class II (special controls). The special control is FDA's guidance document entitled “Class II Special Controls Guidance Document: Sirolimus Test Systems.” See § 862.1(d) for the availability of this guidance document.

[69 FR 58259, Sept. 30, 2004]

Mycophenolic Acid Test System

Page Type
Product Code
Definition
An in vitro diagnostic reagent system intended for use in the quantitative determination of total mycophenolic acid in human serum or plasma as an aid in the management of mycophenolic acid therapy in renal and cardiac transplant patients.
Physical State
Liquid
Technical Method
Enzyme-mimicking assay with MPA concentration inversely proportional to the formation of NADH.
Target Area
Renal and Cardiac Transplant Patients
Regulation Medical Specialty
Toxicology
Review Panel
Toxicology
Submission Type
510(K)
Device Classification
Class 2
Regulation Number
862.3840
GMP Exempt?
No
Summary Malfunction Reporting
Eligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Third Party Eligible

CFR § 862.3840 Sirolimus test system

§ 862.3840 Sirolimus test system.

(a) Identification. A sirolimus test system is a device intended to quantitatively determine sirolimus concentrations in whole blood. Measurements are used as an aid in management of transplant patients receiving therapy with sirolimus.

(b) Classification. Class II (special controls). The special control is FDA's guidance document entitled “Class II Special Controls Guidance Document: Sirolimus Test Systems.” See § 862.1(d) for the availability of this guidance document.

[69 FR 58259, Sept. 30, 2004]